GALLAI, Virgilio
 Distribuzione geografica
Continente #
EU - Europa 2.526
NA - Nord America 2.292
AS - Asia 594
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.420
Nazione #
US - Stati Uniti d'America 2.282
UA - Ucraina 691
SE - Svezia 670
IE - Irlanda 479
HK - Hong Kong 214
FI - Finlandia 148
SG - Singapore 131
IT - Italia 130
VN - Vietnam 128
DE - Germania 125
RU - Federazione Russa 102
GB - Regno Unito 99
CN - Cina 80
FR - Francia 23
CH - Svizzera 16
KR - Corea 14
AT - Austria 10
TR - Turchia 10
CA - Canada 9
NL - Olanda 8
BE - Belgio 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
AU - Australia 5
PL - Polonia 5
GR - Grecia 4
LB - Libano 4
IR - Iran 2
BG - Bulgaria 1
BR - Brasile 1
EU - Europa 1
IN - India 1
JP - Giappone 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.420
Città #
Dublin 479
Chandler 442
Jacksonville 413
San Mateo 237
Hong Kong 214
Dong Ket 128
Medford 114
Princeton 114
Wilmington 105
Singapore 87
Ashburn 81
Ann Arbor 73
Altamura 55
Andover 49
Lawrence 45
Woodbridge 37
Saint Petersburg 36
Helsinki 35
Beijing 28
Shanghai 28
Des Moines 27
Auburn Hills 20
Philadelphia 18
Norwalk 17
Boardman 16
San Paolo di Civitate 14
Seoul 14
Izmir 10
Los Angeles 10
Rome 10
Houston 8
Ottawa 8
Brussels 7
Den Haag 7
Bologna 6
Perugia 6
Barcellona Pozzo di Gotto 5
Adelaide 4
Moscow 4
Redmond 4
Chicago 3
Frankfurt Am Main 3
New York 3
Brno 2
Catania 2
Milan 2
Salerno 2
Bay of Plenty 1
Bratislava 1
Chiang Mai 1
Collazzone 1
Dearborn 1
Edinburgh 1
Ferrara 1
Florence 1
Fremont 1
Groningen 1
Guelph 1
Kiev 1
Lausanne 1
Mariano Comense 1
Mexico City 1
Monzuno 1
Nanchang 1
Nanning 1
Naples 1
Napoli 1
New Delhi 1
Paris 1
Parma 1
Perth 1
Pitesti 1
Redwood City 1
San Diego 1
Spoltore 1
Taranto 1
Teresina 1
Terni 1
Tokyo 1
Totale 3.064
Nome #
A new assay for antiphospholipid antibodies in patient with ischemic stroke 106
Cerebrospinal fluid peptides, aminoacids and monoamine metabolites in lumbar puncture headache 98
Adhesion molecules and integrin expression by lymphocytes in the internal jugular blood of migraine patients during attacks. 88
a-D-Mannosidses in patients with familial Alzheimer's Disease 84
a-D-Mannosidases in patients with Alzheimer's disease 83
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 82
Swalloving dysfunction: neurovascolar- anatomical correlation. 81
Trattamento sintomatico dell'emicrania giovanile.(Juvenile Migraine: Symptomatic Treatment) 77
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 75
Normal pressure hydrocephalus and basilar artery aneurysm. Case report and pathogenic consideration 74
Excitotoxic effect of high frequency stimulation during hypoxia in hippocampal slices: neuroprotection by AP-5, a selective NMDA receptor antagonist 73
Trattamento fibrinolitico nell’ictus acuto: una terapia costosa od un risparmio per la comunità? 72
Disturbi dell'equilibrio nei pazienti con cefalea primaria: entità reale o soggettiva? Valutazione qualitativa e quantitativa mediante stabilometria statica - Atti XVI Conresso Nazionale "Cefalee ed età della vita" 72
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 72
Flow chart diagnostica nella cefalea giovanile 71
Nitric oxide pathway, Ca and serotonin levels in platelets of patients affected by chronic daily headache: relationship with drug abuse 70
Studio della tensione muscolare mediante EMG-BFB e valutazione neuropsicologica 70
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 69
Outcome of Juvenile headache in outpatients attending 23 Italian Headache Clinics 69
NFKB and inducible Nitric oxide synthase mRNA and protein expression by monocytes from internal jugular blood of migraine without aura assesed during attacks. 69
Neurotransmitter abnormalities in cerebrospinal fluid of patients with lumbar puncture headache. 69
La cefalea al risveglio. 68
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 67
XIV Congresso Nazionale SISC: Le cefalee verso il terzo millennio. (Atti del) 66
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 66
Brain SPECT in the diagnosis of degenerative dementia. 66
Application of the 1988 International Headache Society diagnostic criteria in nine Italian headache centers using a computerized structured record 64
Activity levels of a beta1,6 N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients 64
Sindrome da sospensione di barbiturici in un paziente con cefalea cronica quotidiana. 63
L-arginine/nitric oxide patway, serotonin and calcium levels in platelets of patients with chronic daily headache with and without analgesic abuse. 63
Event related potentials in post-traumatic headache 63
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 63
Iter diagnostico e flow chart della cefalea giovanile 62
Emgraphical ischemic test and MG++ concentration in Juvenile headache 62
Linee guida: iter diagnostico della cefalea giovanile 62
An open label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxys of migraine 62
Headache characteristics in obstructive sleep apnea syndrome. 61
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 60
Activation of complement and contact system in Alzheimer’s disease 59
Relazione tra ossido nitrico e metabolismo prostaglandinico nell'attacco spontaneo di emicrania. 58
Electromyographical ischemic test, clinical symptoms related to neuromuscular hyperexcitability, and intra and extra cellular Mg levels in headache patients 58
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 56
Emissione di idrocarburi volatili e stress ossidativo nelle apnee ostruttive nel sonno (SAOS). 54
Atrial fibrillation and stroke. 54
Emissione di idrocarburi volatili e stress ossidativo nelle apnee ostruttive nel sonno (SAOS) 53
Cluster headache in childhood and adolescence: one year prevalence in an out-patient population. 52
Brain SPECT in different dementia disorders: AD, Possible AD, Preclinical AD, AAMI, FTD, LBD, VaD, secondary dementia. 52
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study 52
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors 50
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients. 50
Nerve Growth factor in the cerebrospinal fluid of patients affected by chronic daily headache 49
Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene : a study in an Italian population with dementia 48
Mild Hyperhomocyst(e)inemia: A possible Risk Factor for Cervical Artery Dissection 47
Serum paraoxonase activity in early phases of acute ischemic stroke. VIII European Stroke Conference 47
Neuron Specific Enolase (NSE), beta-amyloid and tau proteins as markers of dementia. 46
Phospholipid autoantibodies: time for a new immuno-assay? 46
Brain CT scan in acute ischemic stroke: early signs and functional outcome. 45
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 45
Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge. 44
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 44
Brain-derived neurotrophic factor in patients with multiple sclerosis. 43
Cefalee secondarie a lesioni espansive endocraniche. 42
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis 41
Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice. 40
Heart-brain relationship: atrial fibrillation and stroke. 40
Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease 40
Pharmacological treatment of non-cognitive disturbances in dementia disorders. 40
Emicrania: eziopatogenesi clinica e terapia 40
Glutamate and nitric oxide in chronic daily headache : mediators of central sensitization? 39
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. 39
Funzionalità piastrinica e attività NO sintasica nella cefalea di tipo tensivo cronico 38
Dysphagia following Stroke. 37
The Perugia hospital-based Stroke Registry: report of the 2nd year. 37
Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion? 37
Vertebral artery dissection and hyperhomocysteinemia: a case report. 36
Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis treated with IFN-beta 1A. 35
Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke 35
Brain CT-scan in acute stroke patients: silent infarcts and relation to outcome. 35
Corso Nazionale di Aggiornamento SISC (Abstract del) 35
Diagnosi differenziale tra cefalee primarie e secondarie di interesse neurologico 35
Prestroke dementia in patients with atrial fibrillation. Frequency and associated factors. 34
CSF Neuron Specific Enolase as a biological marker of Alzheimer's disease and subcortical vascular dementia. 34
Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. 34
Cerebrospinal fluid pyruvate levels in Alzheimer’s Disease and vascular dementia 34
Magnetization transfer changes of grey and white matter in Parkinson’s disease 32
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 32
Role of neuroprotective drugs in acute ischemic stroke. 32
Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. 32
Disturbi del sonno nelle cefalee primarie. 32
The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients 31
Normal pressure hydrocephalus and basilar artery aneurysm 31
Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. 30
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. 30
Event-related potentials in posttraumatic headache. 30
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators. 30
Recanalization of cervical artery dissection: influencing factors and role in neurological outcome. 30
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's 29
Treatment of cognitive dysfunction associated with Alzheimer’s disease with colinergic precursors. Ineffective treatments or inappropriate approaches? 29
Intracellular Mg++ concentration and Emgraphical ischemic test in Juvenile headache 29
Clinical and genetic analysis of hereditary and sporadic ataxia in central Italy 28
Totale 5.202
Categoria #
all - tutte 20.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020552 8 5 104 4 103 4 101 14 102 19 12 76
2020/20211.435 3 100 80 100 329 131 112 5 199 69 144 163
2021/2022934 36 205 57 104 25 0 9 266 4 7 100 121
2022/20231.478 118 173 21 111 136 172 4 64 629 1 36 13
2023/2024579 40 62 35 6 3 11 86 42 123 11 67 93
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 5.573